The Vdr: Why Your Vitamin D3 Might Not Be Protecting Your Ageing Brain
Quick Read Vitamin D does more than support bones. It acts as a signalling molecule that switches genes on and
We write a new article on supplements every day , all detailed, with citations.
Once a week we send an email containing a list of the last 7 days articles. Please sign up and also feel free to share the articles with friends and family who you think might benefit.
Simon Parrott – Vitacuity Ltd
Multiple large studies show that people who drink coffee regularly have lower rates of dementia and cognitive decline. Coffee contains hundreds of compounds beyond caffeine that may protect the brain by reducing inflammation, cutting oxidative stress, and interfering with protein buildup linked to Alzheimer’s disease. Research suggests the protective effect is most consistent between one and three cups daily, roughly 200 to 400 milligrams of caffeine.
A major UK study of nearly 119,000 people found that regular coffee and tea drinkers had significantly lower dementia risk over 13 years, with benefits strongest in people who were overweight or had high blood pressure. A Japanese study following people over 20 years found that older adults drinking one or more cups daily had 46 percent lower odds of significant cognitive decline. However, the evidence comes entirely from observational studies watching people’s habits, not randomized trials proving coffee causes the benefit.
Important limitations exist: different studies show conflicting results in some populations, the type of coffee matters but isn’t tracked in research, and we cannot rule out that coffee drinkers simply have other healthy habits. Beyond three cups daily, the benefit appears to plateau or weaken, and excessive caffeine can disrupt sleep, which itself damages brain health.
Verdict: Moderate coffee consumption sits consistently with lower dementia risk across large populations, has plausible biological mechanisms, and is safe and affordable, making it a reasonable part of a brain-protective routine if consumed one to three cups daily before afternoon.
What if one of the most effective things you could do for your brain health is already sitting in your kitchen every morning? Not a supplement protocol, not a complex lifestyle overhaul, just a cup of coffee. Before you dismiss this as too good to be true, or assume this is another breathless headline overstating a weak correlation, hold on. Vitacuity reviewed over 1.77 million research papers and selected the most relevant studies on this topic, and the picture that emerges is more nuanced, more interesting, and frankly more credible than most headlines suggest. Coffee isn’t a magic bullet. But the consistency of the signal across very large populations is hard to ignore. Here’s what the research actually shows, and, just as importantly, where the science gets complicated.
To understand why coffee might protect the brain, you first need to understand what’s actually in your cup. Coffee is far more complex than most people realise. Beyond caffeine, which most people know as the thing that stops you falling asleep at your desk, coffee contains hundreds of bioactive compounds including polyphenols, chlorogenic acid, trigonelline, and caffeic acid [1][12].
Caffeine’s most studied mechanism involves blocking adenosine receptors in the brain. Adenosine is a naturally occurring chemical that builds up throughout the day and makes you feel progressively sleepier. Caffeine essentially sits in the same receptor “seat” that adenosine would occupy, blocking its drowsiness-inducing signal. But researchers now think this is only part of the story, and the full mechanism isn’t yet clearly understood [1].
What’s emerging is a picture of coffee as a multi-pathway compound. Research has identified that coffee’s constituents, particularly caffeine, chlorogenic acid, and trigonelline, may act on several key mechanisms involved in Alzheimer’s disease development, including amyloidopathy (the build-up of amyloid plaques), tauopathy (the tangling of tau proteins), and neuroinflammation [12]. These compounds appear to work through modulating inflammatory pathways including NF-κB and Nrf2, two molecular switches that play significant roles in how the brain responds to damage and oxidative stress [12].
In plain English: coffee may be doing several jobs at once, blocking inflammatory signals, reducing oxidative stress, and potentially interfering with the very protein mechanisms that drive Alzheimer’s pathology. That’s a meaningful mechanistic case. Not proven causation, but a biologically plausible explanation for the associations we see in population data.
Evidence grade: Promising, consistent signals across multiple observational studies, but we lack large randomised controlled trials
A 2025 systematic review published in a peer-reviewed journal, covering studies across PubMed/MEDLINE, Embase, Web of Science, and the Cochrane Library through October 2024, found that higher caffeine intake (more than 200mg per day, roughly two standard cups of coffee) was consistently associated with a reduced risk of cognitive decline and Alzheimer’s disease progression [2].
One particularly striking finding from this review: plasma caffeine levels exceeding 1,200 ng/ml were linked to a significantly reduced risk of converting from mild cognitive impairment (MCI) to full dementia [2]. This matters because MCI is often the critical window, the stage where intervention might actually slow or prevent progression to Alzheimer’s disease.
The review also included a Mendelian randomisation study, a method that uses genetic variants to test causation rather than just correlation, which suggested a protective effect of genetically higher plasma caffeine levels against Alzheimer’s disease, with an odds ratio of 0.87. That’s roughly a 13% reduced odds of Alzheimer’s. The catch: this finding didn’t quite reach statistical significance [2]. It’s directionally consistent but not yet definitive.
A separate 2023 meta-analysis of 11 studies specifically examining daily coffee consumption and Alzheimer’s risk reached broadly similar conclusions, finding that regular coffee consumption was associated with a meaningful reduction in Alzheimer’s risk [13].
Evidence grade: Promising, very large sample, long follow-up, but observational rather than interventional
One of the most impressive datasets in this area comes from the UK Biobank, a prospective cohort study that is about as large as observational nutrition research gets. A 2026 study drawing on 118,963 dementia-free participants (followed from 2006–2010 baseline) tracked beverage consumption and incident dementia over an average of 13.45 years, during which 992 all-cause dementia cases were recorded [5].
The findings were striking in their clarity. Coffee and tea consumption were both independently associated with lower dementia risk. Meanwhile, drinking more than one glass per day of sugar-sweetened beverages was associated with a 61% increased risk of all-cause dementia (hazard ratio 1.61, 95% CI: 1.28–2.02) [5].
The study also ran substitution modelling, essentially asking: what happens mathematically if someone swaps a sugary drink for coffee or tea? The answer was a significant reduction in dementia risk. And importantly, these protective associations were strongest among individuals who already had obesity, hypertension, depression, or dyslipidaemia, the very people we’d most want to help [5].
A separate UK Biobank analysis from 2025 examined cognitive decline specifically (rather than diagnosed dementia), and again found that moderate coffee and tea consumption was associated with slower cognitive decline over time [4][11].
Evidence grade: Promising, long follow-up, real-world populations, but moderate sample size
The JPHC Saku Mental Health Study, published in 2025, is notable for its extraordinary time horizon. This population-based cohort study enrolled 1,155 participants aged 44–66 in 1995, assessed their dietary habits in 1995 and again in 2000, and then conducted neuropsychological evaluations between 2015 and 2025, giving researchers a roughly 20-year window to observe what happened [3].
The results for coffee: in older participants (those aged 53 or above at baseline in 1995), consuming one or more cups of coffee daily was associated with a significantly reduced risk of significant cognitive decline, with an odds ratio of 0.54 (95% CI: 0.34–0.84) after adjusting for confounding factors [3]. That’s roughly a 46% reduced odds of significant cognitive decline in that subgroup, a substantial signal.
Interestingly, this protective effect was not statistically significant in the sample as a whole, only when researchers stratified by age did the coffee benefit emerge clearly. This suggests that coffee’s protective effects on cognition may be particularly relevant for people in mid-to-later life, exactly the Vitacuity readership [3].
Evidence grade: Promising but specific, this finding opens important new questions
One of the most intriguing findings in this space comes from a study published in Annals of Neurology in 2022, which drew on two cohorts: 888 older participants from the Rush Memory and Aging Project (MAP), who consented to post-mortem brain examination, and 303,887 participants from the UK Biobank [6].
In the UK Biobank arm, there was a clear protective association between caffeine intake and all-cause dementia. Compared to those consuming 100mg or less per day, those consuming 200–300mg/day had a 26% lower hazard of all-cause dementia (HR: 0.74, 95% CI: 0.64–0.85), and those consuming 300–400mg/day had the same 26% reduction [6].
But the MAP arm, which included post-mortem neuropathology, produced a counterintuitive finding: in this smaller cohort, higher caffeine intake was actually associated with a slightly increased hazard of Alzheimer’s dementia diagnosis. However, and this is the crucial part, caffeine intake was inversely associated with Lewy body pathology. Those consuming more than 100mg/day had 60% lower odds of neocortical Lewy bodies (odds ratio: 0.40, 95% CI: 0.21–0.75) [6].
Lewy bodies are protein deposits associated with Parkinson’s disease dementia and Lewy body dementia, distinct from the amyloid plaques of classic Alzheimer’s. The researchers suggest this may explain why results vary across studies: coffee may be most protective against Lewy body-type neurodegeneration, rather than classical Alzheimer’s pathology. If different populations have different mixes of underlying dementia types, you’d expect inconsistent results, which is exactly what we see [6].
Evidence grade: Promising, consistent pattern across multiple studies, though exact optimal dose remains unclear
Across multiple studies, a pattern emerges: moderate consumption appears to be the sweet spot. The 2024 review on coffee and Alzheimer’s disease suggests two to three cups daily as the range associated with potential neuroprotective benefits [12]. The 2025 systematic review points to more than 200mg/day (roughly two cups) as the level where cognitive protection becomes consistent [2].
The Japanese green tea data adds an interesting cautionary note: 2–3 cups of green tea daily showed significant cognitive protection (OR: 0.56), but four or more cups lost statistical significance [3]. The Murakami cohort study of 13,660 participants found that high combined consumption of both green tea and coffee was not associated with lower dementia risk, in fact there appeared to be an interaction effect suggesting that excessive combined intake isn’t additive [14].
In the UK Biobank caffeine study, the highest caffeine intake category (more than 400mg/day) showed a slightly attenuated benefit (HR: 0.92, 95% CI: 0.79–1.08) compared to the 200–400mg ranges, which showed stronger reductions [6]. This is consistent with a dose-response curve that flattens, or possibly curls back, at very high intakes.
The practical implication: one to three cups of coffee per day sits in the zone where the evidence is most consistent. Drinking six cups a day isn’t clearly better, and brings its own issues with sleep, anxiety, and cardiovascular stress, none of which are good for brain health in the long run.
This is where intellectual honesty matters, and where we think it’s important to be straight with you.
We don’t have randomised controlled trials. Almost all of the evidence here is observational, meaning we’re watching what people who drink coffee do over time, not randomly assigning people to drink coffee versus not and measuring outcomes. Observational studies can be confounded: maybe coffee drinkers have other healthier habits, different social lives, or different genetic profiles that actually explain the lower dementia rates. Researchers try to adjust for these factors, but they can’t adjust for what they don’t measure [1][2].
The conflict in the data is real. The 2022 Annals of Neurology study [6] produced results that genuinely contradicted each other between its two cohorts. A 2015 meta-analysis of observational studies found inconsistent findings across the literature [10]. These aren’t minor statistical wobbles, they’re substantive disagreements. The most plausible explanation is that different populations have different underlying dementia pathologies, and coffee may protect against some (particularly Lewy body-related) more than others. But this is still a hypothesis, not settled science.
The genetic factor is real but under-studied. The Mendelian randomisation data suggests genetics may influence how much benefit you get from caffeine [2]. People metabolise caffeine differently, some are “fast metabolisers” and some are “slow metabolisers”, and this likely affects both how much caffeine reaches the brain and for how long. We don’t yet know how to use this information practically.
The “coffee” problem. As the 2025 narrative review notes, “coffee” is not one thing [1][7]. Espresso, filter coffee, instant coffee, cold brew, these have vastly different caffeine levels and different polyphenol profiles. Almost none of the studies control for this. When someone reports “two cups of coffee,” we genuinely don’t know what that means in terms of active compounds.
We don’t know whether coffee is the active ingredient or a marker. It’s possible that people who have the social habits, daily routines, and psychological profiles that lead them to drink coffee regularly are also doing a dozen other brain-protective things. The coffee might be a flag, not the cause.
Here’s the sensible, informed position: the evidence that moderate coffee consumption is associated with lower dementia risk is consistent, spans very large populations, has biologically plausible mechanisms, and has been replicated across multiple countries and study designs. It’s not proven causation. But when something is safe, enjoyable, affordable, and shows a consistent signal across the data, the pragmatic conclusion is: lean into it.
If you already drink one to three cups of coffee per day, you’re sitting in the zone where the evidence is most encouraging. There’s no clear signal that you need to change anything. If you drink significantly more than that, the data suggests the additional benefit is minimal and the sleep disruption risk is real, poor sleep is itself a risk factor for cognitive decline, so high caffeine intake late in the day may be actively working against you.
If you don’t drink coffee at all, due to intolerance, preference, or anxiety, the evidence on tea is similarly encouraging [4][5][11], and switching from sugary drinks to tea or coffee is one of the most clearly supported substitutions in the dementia prevention data [5].
A few practical pointers grounded in the research:
– Aim for one to three cups before 2pm. This keeps you in the evidence-supported range and avoids the sleep disruption that comes with afternoon caffeine [2][12]. – Don’t go far above 400mg of caffeine daily. The benefit curve appears to flatten or attenuate above this threshold, and you’re adding cardiovascular stress without clear additional brain benefit [6]. – Think of coffee as one layer of a broader approach. The UK Biobank data shows the protective effect of coffee was strongest in people who already had metabolic risk factors like obesity and hypertension [5]. That’s not a reason to use coffee as a substitute for addressing those conditions, it’s a reason to address all of them. – If you’re in midlife (40s–50s), now is the time. The Japanese cohort data suggests that coffee habits formed in midlife may be particularly relevant to brain health decades later [3]. Habits built now may matter more than habits started at 70. – Green tea is a legitimate alternative, but not a simple substitute for coffee. The interaction data suggests that piling on both at very high quantities isn’t additive, and may actually be less beneficial than moderate consumption of either [14].
Coffee won’t guarantee you a sharp mind at 80. Nothing will. But among the cheap, accessible, pleasurable daily habits that the research consistently associates with lower dementia risk, your morning coffee earns its place at the table.
[1] Neurocognitive and Neurological Effects of Coffee and Caffeine: A Narrative Review (2025). DOI: 10.7759/cureus.94742 | https://pubmed.ncbi.nlm.nih.gov/41246694/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12619674/
[2] Association Between Caffeine Intake and Alzheimer’s Disease Progression: A Systematic Review (2025). https://pubmed.ncbi.nlm.nih.gov/40255824/
[3] A longitudinal cohort study demonstrating the beneficial effect of moderate consumption of green tea and coffee on the prevention of dementia: The JPHC Saku Mental Health Study (2025). DOI: 10.1177/13872877241303709 | https://pubmed.ncbi.nlm.nih.gov/39772974/
[4] Moderate coffee and tea consumption is associated with slower cognitive decline (2025). DOI: 10.1177/13872877251361058 | https://pubmed.ncbi.nlm.nih.gov/40686251/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12361686/
[5] Associations of Individual Beverage Types and Substitution with Dementia Risk: A UK Biobank Cohort Study (2026). DOI: 10.1016/j.jnha.2025.100740 | https://pubmed.ncbi.nlm.nih.gov/41314057/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12702361/
[6] Caffeine Consumption and Dementia: Are Lewy Bodies the Link? (2022). DOI: 10.1002/ana.26349 | https://pubmed.ncbi.nlm.nih.gov/35288978/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310711/
[7] Neurocognitive and Neurological Effects of Coffee and Caffeine: A Narrative Review (2025). DOI: 10.7759/cureus.94742 | https://pubmed.ncbi.nlm.nih.gov/41246694/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12619674/
[10] Caffeine intake from coffee or tea and cognitive disorders: a meta-analysis of observational studies (2015). https://pubmed.ncbi.nlm.nih.gov/25721193/
[11] Moderate coffee and tea consumption is associated with slower cognitive decline (2025). DOI: 10.1177/13872877251361058 | https://pubmed.ncbi.nlm.nih.gov/40686251/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12361686/
[12] Coffee and Alzheimer’s disease (2024). https://pubmed.ncbi.nlm.nih.gov/39168581/
[13] Effect of Daily Coffee Consumption on the Risk of Alzheimer’s Disease: A Systematic Review and Meta-Analysis (2023). https://pubmed.ncbi.nlm.nih.gov/37970326/
[14] Green tea consumption and dementia risk in community-dwelling Japanese people aged 40-74 years: A 12-year cohort study (2025). DOI: 10.1016/j.jnha.2025.100615 | https://pubmed.ncbi.nlm.nih.gov/40561856/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12402371/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Vitamin D does more than support bones. It acts as a signalling molecule that switches genes on and
Quick Read Creatine is known as a muscle-building supplement, but research suggests it may be equally important for brain health,
Free guide: The research behind brain health supplements
Plus our weekly research digest — straight to your inbox.
Just leave your email address.